KalVista Pharmaceuticals, Inc. (KALV)

15.83 -0.06 (-0.38%) USD  |  NASDAQ  |  Feb 20, 16:00
15.80 -0.03 (-0.19%) After-Hours: 20:00
More

KalVista Pharmaceuticals Underperform Recommendations

Underperform Recommendations Chart

View Underperform Recommendations for KALV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Underperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Underperform Recommendations Range, Past 5 Years

View Underperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Underperform Recommendations Benchmarks

View Underperform Recommendations Benchmarks
Start Trial
BioCryst Pharmaceuticals, Inc. Upgrade
Modular Medical, Inc. Upgrade
Iovance Biotherapeutics, Inc. Upgrade
Plus Therapeutics, Inc. Upgrade
BioStem Technologies, Inc. Upgrade